Comera Life Sciences Holdings, Inc.
Symbole: CMRA
NASDAQ
0.02684
USDPrix du marché aujourd'hui
-0.0074
Ratio P/E
0.0000
Ratio PEG
1.17M
Cap MRK
- 0.00%
Rendement DIV
Comera Life Sciences Holdings, Inc. (CMRA) États financiers
Bilan
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | |||
---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 4.23 | 0.4 | 6.5 | 0.2 | |||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | |||
balance-sheet.row.net-receivables | 0.63 | 0 | 0.2 | 0.1 | |||
balance-sheet.row.inventory | 3.98 | 2.5 | 0 | 0 | |||
balance-sheet.row.other-current-assets | 1.08 | 0.1 | 0 | 0 | |||
balance-sheet.row.total-current-assets | 9.93 | 3.1 | 6.8 | 0.3 | |||
balance-sheet.row.property-plant-equipment-net | 1.84 | 0.6 | 0.6 | 0.2 | |||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | |||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 0 | 0 | |||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | |||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||
balance-sheet.row.other-non-current-assets | 0.37 | 0.1 | 0.1 | 0.1 | |||
balance-sheet.row.total-non-current-assets | 2.21 | 0.7 | 0.6 | 0.2 | |||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||
balance-sheet.row.total-assets | 12.14 | 3.7 | 7.4 | 0.5 | |||
balance-sheet.row.account-payables | 6.53 | 1.5 | 0.4 | 0.1 | |||
balance-sheet.row.short-term-debt | 1.85 | 0.7 | 0.1 | 0.1 | |||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||
balance-sheet.row.long-term-debt-total | 0.17 | 0.1 | 0.2 | 0.2 | |||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | |||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||
balance-sheet.row.other-current-liab | 5.52 | 2.8 | 0 | 0 | |||
balance-sheet.row.total-non-current-liabilities | 18.92 | 4.9 | 21.1 | 0.2 | |||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||
balance-sheet.row.capital-lease-obligations | 0.98 | 0.3 | 0.3 | 0 | |||
balance-sheet.row.total-liab | 34.22 | 10 | 22.1 | 0.4 | |||
balance-sheet.row.preferred-stock | 13622.31 | 4517.7 | 20.9 | 0 | |||
balance-sheet.row.common-stock | 0.01 | 0 | 0 | 10.7 | |||
balance-sheet.row.retained-earnings | -152.04 | -34.9 | -16.9 | -11.4 | |||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -9017.78 | 0 | -20.9 | 0 | |||
balance-sheet.row.other-total-stockholders-equity | -4474.58 | -4489.1 | 2.2 | 0.9 | |||
balance-sheet.row.total-stockholders-equity | -22.08 | -6.2 | -14.7 | 0.2 | |||
balance-sheet.row.total-liabilities-and-stockholders-equity | 12.14 | 3.7 | 7.4 | 0.5 | |||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||
balance-sheet.row.total-equity | -22.08 | -6.2 | -14.7 | 0.2 | |||
balance-sheet.row.total-liabilities-and-total-equity | 12.14 | - | - | - | |||
Total Investments | 0 | 0 | 0 | 0 | |||
balance-sheet.row.total-debt | 2.02 | 0.8 | 0.3 | 0.2 | |||
balance-sheet.row.net-debt | -2.2 | 0.3 | -6.2 | 0 |
Tableau des flux de trésorerie
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | |||
---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -9.01 | -18 | -5.5 | -2.1 | |||
cash-flows.row.depreciation-and-amortization | 0.1 | 0.1 | 0.1 | 0.1 | |||
cash-flows.row.deferred-income-tax | -0.08 | 0 | -0.2 | 0 | |||
cash-flows.row.stock-based-compensation | 1 | 0.4 | 1.1 | 0.1 | |||
cash-flows.row.change-in-working-capital | 1.41 | 2.6 | 0.6 | 0 | |||
cash-flows.row.account-receivables | 0.29 | 0 | 0.1 | -0.1 | |||
cash-flows.row.inventory | 0.51 | 0 | 0.2 | 0.1 | |||
cash-flows.row.account-payables | -0.4 | 0.9 | 0.3 | 0 | |||
cash-flows.row.other-working-capital | 1 | 1.7 | 0 | 0 | |||
cash-flows.row.other-non-cash-items | -0.08 | 5.2 | 0.1 | 0.2 | |||
cash-flows.row.net-cash-provided-by-operating-activities | -6.66 | 0 | 0 | 0 | |||
cash-flows.row.investments-in-property-plant-an-equipment | -28.68 | 0 | -0.1 | 0 | |||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | |||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | |||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | |||
cash-flows.row.other-investing-activites | 0.01 | 0 | 0 | 0 | |||
cash-flows.row.net-cash-used-for-investing-activites | -28.66 | 0 | -0.1 | 0 | |||
cash-flows.row.debt-repayment | 0 | 0 | 0 | 0 | |||
cash-flows.row.common-stock-issued | 0.13 | 0.8 | 0 | 1.4 | |||
cash-flows.row.common-stock-repurchased | 650 | 650 | 0 | 0 | |||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||
cash-flows.row.other-financing-activites | -644.28 | -645.6 | 10.3 | 0.2 | |||
cash-flows.row.net-cash-used-provided-by-financing-activities | 5.85 | 5.2 | 10.3 | 1.6 | |||
cash-flows.row.effect-of-forex-changes-on-cash | 28.57 | 0 | 0 | 0 | |||
cash-flows.row.net-change-in-cash | -0.9 | -4.6 | 6.4 | -0.3 | |||
cash-flows.row.cash-at-end-of-period | 5.94 | 2 | 6.6 | 0.2 | |||
cash-flows.row.cash-at-beginning-of-period | 6.84 | 6.6 | 0.2 | 0.4 | |||
cash-flows.row.operating-cash-flow | -6.66 | -9.8 | -3.8 | -1.8 | |||
cash-flows.row.capital-expenditure | -28.68 | 0 | -0.1 | 0 | |||
cash-flows.row.free-cash-flow | -35.34 | -9.8 | -3.9 | -1.8 |
Row du compte de résultat
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | |||
---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1 | 0.6 | 0.3 | 0.4 | |||
income-statement-row.row.cost-of-revenue | 0.26 | 0.2 | 0.2 | 0.1 | |||
income-statement-row.row.gross-profit | 0.74 | 0.4 | 0.2 | 0.3 | |||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||
income-statement-row.row.research-development | 1.43 | - | - | - | |||
income-statement-row.row.selling-general-administrative | 8.45 | - | - | - | |||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||
income-statement-row.row.other-expenses | 0 | -1.5 | -0.1 | 0 | |||
income-statement-row.row.operating-expenses | 9.88 | 12.4 | 5.7 | 2.5 | |||
income-statement-row.row.cost-and-expenses | 10.15 | 12.6 | 5.9 | 2.6 | |||
income-statement-row.row.interest-income | 0.03 | 0 | 0 | 0 | |||
income-statement-row.row.interest-expense | 0.03 | 0 | 0 | 0 | |||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||
income-statement-row.row.total-other-income-expensenet | 0.15 | -6 | 0.1 | 0 | |||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||
income-statement-row.row.other-operating-expenses | 0 | -1.5 | -0.1 | 0 | |||
income-statement-row.row.total-operating-expenses | 0.15 | -6 | 0.1 | 0 | |||
income-statement-row.row.interest-expense | 0.03 | 0 | 0 | 0 | |||
income-statement-row.row.depreciation-and-amortization | 0.1 | -1.4 | -0.1 | 0.1 | |||
income-statement-row.row.ebitda-caps | -9.07 | - | - | - | |||
income-statement-row.row.operating-income | -9.15 | -12 | -5.5 | -2.1 | |||
income-statement-row.row.income-before-tax | -9.01 | -18 | -5.5 | -2.1 | |||
income-statement-row.row.income-tax-expense | 75.23 | 6 | -0.2 | 0 | |||
income-statement-row.row.net-income | -84.25 | -24 | -5.3 | -2.1 |
Questions fréquemment posées
Quel est le total de Comera Life Sciences Holdings, Inc. (CMRA) de l'actif total?
Comera Life Sciences Holdings, Inc. (CMRA) Le total des actifs est 3727113.000.
Quel est le revenu annuel de l'entreprise?
Le revenu annuel est 451365.000.
Quelle est la marge bénéficiaire de l'entreprise?
La marge bénéficiaire de l'entreprise est 0.735.
Quel est le flux de trésorerie disponible de l'entreprise?
Le flux de trésorerie disponible est -1.529.
Quelle est la marge bénéficiaire nette de l'entreprise?
La marge bénéficiaire nette est -84.219.
Quel est le revenu total de l'entreprise?
Le revenu total est -9.143.
Qu'est-ce que Comera Life Sciences Holdings, Inc. (CMRA) bénéfice net (revenu net)?
Le bénéfice net (revenu net) est -24038181.000.
Quel est l'endettement total de l'entreprise?
La dette totale est 775048.000.
Quel est le montant des dépenses d'exploitation?
Les dépenses d'exploitation sont 12392727.000.
Quel est le montant de la trésorerie de l'entreprise?
Les liquidités de l'entreprise sont 1767870.000.